Search
Chairs and Members
Chair
Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, Guy’s Hospital, London (United Kingdom)
Co-chair
Jean-Jacques Kiladjian, Hôpital Saint-Louis and Paris Diderot University, Paris (France)
SWG Steering Committee members
Alessandro Vannucchi, University of Florence (Italy)
Antonio Almeida, Hospital da Luz (Portugal)
Carlos Besses, Barcelona Biomedical Research…
Chairs and Members
ChairUwe Platzbecker, University of Leipzig, Medical Faculty, Clinic and Polyclinic for Hematology, Cellular Therapy and Hemostaseology (Germany)
Co-chairLionel Adès, Hôpital Saint-Louis Paris, Hématologie Seniors (France)
SWG Steering Committee
Pierre Fenaux, Hôpital Saint-Louis, Hématologie Seniors, Paris (France)
Arjan van de Loosdrecht, Amsterdam UMC, Hematology (The…
Chairs and Members
ChairJosep Maria Ribera, Hospital Germans Trias i Pujol (Spain)
Co-chairAdele Fielding, University College London (United Kingdom)
SWG Steering Committee
Anthony Moorman, Newcastle University (United Kingdom)
Cyril Salek, Charles University in Prague (Czechia)
Helene Hallböök, Uppsala University (Sweden)
Nicola Gökbuget, Frankfurt University Cancer Centre (Germany)
Sabina Chiaretti, Sapienza…
Chairs and members
Chair (2024–2027 term)Igor Aurer (education and scientific meetings co-lead) – University Hospital Centre Zagreb, University of Zagreb and KroHem, Croatia
Co-chair (2024–2027 term)Martin Dreyling (guidelines lead) – University Hospital Grosshadern, Ludwig Maximilian University and GLA, Germany
SWG Executive Board members (2024–2027 term)
Kim Linton (scientific secretary) –…
Dates and deadlines
You may find in this page all the dates and deadlines related to the EHA2025 Congress. All deadlines, except if mentioned differently, end at 23:59 CET/CEST.
The timelines will be updated regularly.
Committees and units
The EHA Board sets up committees and units to perform specific tasks and activities.
Read moreEHA to the European Commission and HTA leaders: work with medical societies to involve experts and make joint assessments a success
The speakers of the HTA conference hosted by the European Commission.
Read moreEHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms
Dates: October 12-14, 2017
Location: Budapest, Hungary
Chairs: C Harrison, JJ Kiladjian
EHA and the EHA Scientific Working Group on Myeloproliferative Neoplasms are organizing this EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms.
EHA has joined the European Cancer Organisation - a perfect match on objectives and prioritization
The European Hematology Association (EHA) has joined the European Cancer Organisation, a not-for-profit federation of organizations working in cancer at the European level.
Read moreTARGETING THE JAK-STAT PATHWAY IN MALIGNANT AND NON-MALIGNANT CELLS IN MYELOPROLIFERATIVE NEOPLASMS
Myeloproliferative neoplasms (MPN) are clonal blood disorders characterized by excessive production of mature blood cells. Patients present with large spleens, systemic symptoms, and high levels of circulating inflammatory cytokines.
Read more- «
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- »